Erythrocyte-Coated Nanoparticles Block Cytotoxic Effects of Group B Streptococcus β-Hemolysin/Cytolysin
Group B Streptococcus (GBS) emerged as a leading cause of invasive infectious disease in neonates in the 1970s, but has recently been identified as an escalating public health threat in non-pregnant adults, particularly those of advanced aged or underlying medical conditions. GBS infection can rapid...
Main Authors: | Jenny Koo, Tamara Escajadillo, Liangfang Zhang, Victor Nizet, Shelley M. Lawrence |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-11-01
|
Series: | Frontiers in Pediatrics |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fped.2019.00410/full |
Similar Items
-
Engineered Biomimetic Platelet Membrane-Coated Nanoparticles Block Staphylococcus aureus Cytotoxicity and Protect Against Lethal Systemic Infection
by: Jwa-Kyung Kim, et al.
Published: (2021-08-01) -
A Red Blood Cell Membrane-Camouflaged Nanoparticle Counteracts Streptolysin O-Mediated Virulence Phenotypes of Invasive Group A Streptococcus
by: Tamara Escajadillo, et al.
Published: (2017-07-01) -
PREVALENCIA DE COLONIZACIÓN POR STREPTOCOCCUS AGALACTIAE (GRUPO B) DURANTE EL EMBARAZO PESQUISADO EN MEDIO DE CULTIVO SELECTIVO
by: Enrique Valdés R, et al.
Published: (2004-01-01) -
Streptococcus gallolyticus – A potentially neglected pathogen causing neonatal sepsis not covered by routine group B streptococcus screening
by: Jun Yi Sim, et al.
Published: (2021-12-01) -
Fulminant early-onset neonatal sepsis due to Streptococcus pneumoniae: Case report and review of the literature
by: Carlos Aldana-Valenzuela, et al.
Published: (2019-03-01)